A Study of CS1001 in Subjects With Relapsed or Refractory Extranodal Natural Killer/ T Cell Lymphoma(ENKTL)

Peking University Third Hospital, Beijing

Hunan Cancer Hospital, Changsha

West China Hospital of Sichuan University, Chengdu

Fujian Cancer Hospital, Fuzhou

Sun Yat-sen University Cancer Prevention Center, Guangzhou

Guizhou Cancer Hospital, Guiyang

The First Affiliated Hospital of Zhejiang University, Hangzhou

Zhejiang Cancer Hospital, Hangzhou

Anhui Cancer Hospital, Hefei

Cancer Hospital Affiliated to Guangxi Medical University, Nanning

Fudan University Shanghai Cancer Hospital, Shanghai

Shanghai East Hospital, Shanghai

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

Liaoning Cancer Hospital, Shenyang

Tianjin Cancer Hospital, Tianjin

Cancer Center of Union Hospital, Huazhong University of Science and Technology, Wuhan

Henan Cancer Hospital, Zhengzhou